Abbott Laboratories Share Price
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
116.00 USD | -0.25% | -2.45% | +5.42% |
Capitalization | 202B 192B 179B 159B 284B 17,086B 312B 2,222B 824B 7,006B 758B 741B 30,158B | P/E ratio 2024 * |
34x | P/E ratio 2025 * | 29.3x |
---|---|---|---|---|---|
Enterprise value | 208B 198B 184B 164B 293B 17,633B 321B 2,293B 850B 7,231B 782B 765B 31,122B | EV / Sales 2024 * |
4.96x | EV / Sales 2025 * | 4.6x |
Free-Float |
86.65% | Yield 2024 * |
1.9% | Yield 2025 * | 2.01% |
Last Transcript: Abbott Laboratories
1 day | -0.45% | ||
1 week | -1.42% | ||
Current month | -2.09% | ||
1 month | -1.95% | ||
3 months | +1.42% | ||
6 months | +13.05% | ||
Current year | +5.65% |
Director | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 31/08/2023 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2020 |
Manager | Title | Age | Since |
---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 73 | 09/10/2008 |
Sally Blount
BRD | Director/Board Member | 62 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 08/12/2011 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 20 M€ | +16.48% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.45% | -1.42% | +10.88% | -10.73% | 202B | ||
-0.96% | +0.04% | +7.15% | -19.80% | 110B | ||
-0.70% | -1.33% | -7.13% | -9.36% | 63.97B | ||
+0.07% | +0.64% | +22.52% | +114.16% | 48.33B | ||
-0.75% | +2.58% | +21.29% | +10.81% | 46.62B | ||
+2.02% | +3.81% | -30.62% | -37.70% | 31.6B | ||
0.00% | +0.42% | +31.90% | +34.27% | 30.69B | ||
-0.24% | +0.80% | -8.50% | -25.85% | 23.31B | ||
+0.22% | +0.09% | -6.13% | -8.65% | 22.04B | ||
-1.01% | +0.27% | +6.46% | -1.33% | 21.38B | ||
Average | -0.18% | +0.66% | +4.78% | +4.58% | 59.96B | |
Weighted average by Cap. | -0.39% | +0.14% | +7.37% | +0.20% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42B 39.95B 37.21B 33.17B 59.08B 3,558B 64.86B 463B 172B 1,459B 158B 154B 6,279B | 44.98B 42.79B 39.85B 35.52B 63.27B 3,810B 69.46B 496B 184B 1,562B 169B 165B 6,725B |
Net income | 5.94B 5.65B 5.26B 4.69B 8.35B 503B 9.17B 65.42B 24.25B 206B 22.31B 21.81B 888B | 6.85B 6.52B 6.07B 5.41B 9.64B 580B 10.58B 75.48B 27.99B 238B 25.74B 25.17B 1,024B |
Net Debt | 6.45B 6.14B 5.72B 5.1B 9.08B 546B 9.96B 71.07B 26.35B 224B 24.24B 23.7B 965B | 5.08B 4.84B 4.51B 4.02B 7.15B 431B 7.85B 56.02B 20.77B 177B 19.11B 18.68B 760B |
Date | Price | Change | Volume |
---|---|---|---|
04/12/24 | 116.00 $ | -0.25% | 2,037,852 |
03/12/24 | 116.29 $ | -0.45% | 4,794,886 |
02/12/24 | 116.81 $ | -1.65% | 5,339,311 |
29/11/24 | 118.77 $ | -0.15% | 2,523,194 |
27/11/24 | 118.95 $ | +0.84% | 3,510,309 |
Delayed Quote Nyse, December 03, 2024 at 09:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock
MarketScreener is also available in this country: United States.
Switch edition